Search - tctmd.com

Displaying 41 - 60 of 1583

Sort: Relevancy | Date

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

News Daily News

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

Yael L. Maxwell

June 18, 2025

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Todd Neale

June 06, 2025

News Daily News

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

L.A. McKeown

June 05, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Daily News

Pressure-Based Physiological Testing Results Diverge Between LAD, LCx

Caitlin E. Cox

May 29, 2025

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Yael L. Maxwell

May 15, 2025

News Daily News

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

Todd Neale

May 09, 2025

News Daily News

STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT

Todd Neale

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Yael L. Maxwell

April 29, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Caitlin E. Cox

April 23, 2025

News Daily News

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Caitlin E. Cox

April 17, 2025

Advertisement

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Amylin Analogue Boosts Weight Loss When Added to GLP-1

‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Care Gaps for Women With Cardiogenic Shock Merit Action: SCAI

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Pressure-Based Physiological Testing Results Diverge Between LAD, LCx

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study

STRONG-HF Analysis Quantifies Gains From Rapid Uptake of GDMT

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Knowledge of Genetic Risk for CAD Bolsters Prevention, Reduces MACE

Oral GLP-1 Drug Shines in Phase III ACHIEVE-1 Trial, Lilly Says

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content